About Shattuck Labs
Shattuck Labs is a company based in Austin (United States) founded in 2016.. Shattuck Labs has raised $165.4 million across 7 funding rounds from investors including Fidelity Investments, Orbimed and Janus Henderson Investors. The company has 44 employees as of December 31, 2024. Shattuck Labs offers products and services including SL-325. Shattuck Labs operates in a competitive market with competitors including ALX Oncology, TScan Therapeutics, Lyell Immunopharma, Alpine Immune Sciences and Alector, among others.
- Headquarter Austin, United States
- Employees 44 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Shattuck Labs, Inc.
-
Annual Revenue
$5.72 M245.26as on Dec 31, 2024
-
Net Profit
$-75.41 M13.62as on Dec 31, 2024
-
EBITDA
$-76.52 M12.97as on Dec 31, 2024
-
Total Equity Funding
$165.4 M (USD)
in 7 rounds
-
Latest Funding Round
$103 M (USD), Post-IPO
Aug 26, 2025
-
Investors
Fidelity Investments
& 9 more
-
Employee Count
44
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Shattuck Labs
Shattuck Labs is a publicly listed company on the NASDAQ with ticker symbol STTK in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Shattuck Labs
Shattuck Labs offers a comprehensive portfolio of products and services, including SL-325. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Antagonist for Death Receptor 3 to block TL1A pathway in autoimmune diseases.
Unlock access to complete
Unlock access to complete
Funding Insights of Shattuck Labs
Shattuck Labs has successfully raised a total of $165.4M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $103 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $103.0M
-
First Round
First Round
(22 Aug 2016)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Post-IPO - Shattuck Labs | Valuation | Orbimed |
|
| Jun, 2020 | Amount | Series C - Shattuck Labs | Valuation | Redmile Group | |
| Feb, 2020 | Amount | Series B - Shattuck Labs | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Shattuck Labs
Shattuck Labs has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Orbimed and Janus Henderson Investors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Founded Year | Domain | Location | |
|
Healthcare companies are invested in by this private equity firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Shattuck Labs
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Shattuck Labs
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shattuck Labs Comparisons
Competitors of Shattuck Labs
Shattuck Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ALX Oncology, TScan Therapeutics, Lyell Immunopharma, Alpine Immune Sciences and Alector, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
ALX Oncology is focused on advancing cancer treatment therapies.
|
|
| domain | founded_year | HQ Location |
T cell-based treatments for immunological and oncological disorders are developed.
|
|
| domain | founded_year | HQ Location |
CAR-T and TIL immunotherapies for solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies to treat cancer and autoimmune disorders
|
|
| domain | founded_year | HQ Location |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Antibody drugs for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Shattuck Labs
Frequently Asked Questions about Shattuck Labs
When was Shattuck Labs founded?
Shattuck Labs was founded in 2016.
Where is Shattuck Labs located?
Shattuck Labs is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Is Shattuck Labs a funded company?
Shattuck Labs is a funded company, having raised a total of $165.4M across 7 funding rounds to date. The company's 1st funding round was a Series B of $25.38M, raised on Aug 22, 2016.
How many employees does Shattuck Labs have?
As of Dec 31, 2024, the latest employee count at Shattuck Labs is 44.
What is the annual revenue of Shattuck Labs?
Annual revenue of Shattuck Labs is $5.72M as on Dec 31, 2024.
What does Shattuck Labs do?
Shattuck Labs was founded in 2016 and is headquartered in Austin, United States. The company operates in the biotechnology sector, focusing on oncology and immunology. Its core platform, known as ARC (Agonist Redirected Checkpoints), involves bispecific biologics designed to block checkpoint molecules in cancer while stimulating TNF superfamily costimulatory receptors on T cells and innate immune cells. This approach is applied to various checkpoint targets under clinical development.
Who are the top competitors of Shattuck Labs?
Shattuck Labs's top competitors include Alector, Hummingbird Bioscience and Lyell Immunopharma.
What products or services does Shattuck Labs offer?
Shattuck Labs offers SL-325.
Is Shattuck Labs publicly traded?
Yes, Shattuck Labs is publicly traded on NASDAQ under the ticker symbol STTK.
Who are Shattuck Labs's investors?
Shattuck Labs has 10 investors. Key investors include Fidelity Investments, Orbimed, Janus Henderson Investors, Piper Sandler, and Redmile Group.
What is Shattuck Labs's ticker symbol?
The ticker symbol of Shattuck Labs is STTK on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.